NCT07237425 2025-12-04
Intralesional Ronkyla Plus Injection for the Treatment of Superficial Lipoma
Glonova Pharma Co., Ltd
Phase 1 Recruiting
Clinical Trials
9 trialsNCT05394714 2025-09-23
A Phase I, Autologous ex Vivo Expanded and Activated NK Cell, Magicell-NK, Infusion for Colon Cancer Post Resection Study
Medigen Biotechnology Corporation
Phase 1 Recruiting
NCT03359239 2023-05-16
Atezolizumab Given in Combination With a Personalized Vaccine in Patients With Urothelial Cancer
Icahn School of Medicine at Mount Sinai
Phase 1 Completed
NCT02620748 2022-10-13
TA
George Washington University
Phase 1 Completed
NCT03177252 2020-10-22
Scalp block
Washington University School of Medicine
Phase 1 Withdrawn
NCT03502395 2018-04-19
Serum Opiorphin Level After Intraoperative Intravenous Lidocaine Infusion
Assiut University
Phase 1 Completed
NCT01874561 2016-10-10
Thorough QT/QTc (Corrected QT Interval) Study to Evaluate the Effect of Custirsen on Cardiac Repolarization
Achieve Life Sciences
Phase 1 Completed
NCT00584155 2015-05-27
Protection From Cisplatin Ototoxicity by Lactated Ringers
University of Oklahoma
Phase 1 Withdrawn
NCT01340547 2013-07-18
Effect on QTc, Pharmacokinetics, Safety, and Preliminary Efficacy of Single-agent Palifosfamide-tris in Subjects With Advanced Solid Tumors
Alaunos Therapeutics
Phase 1 Unknown